other

Updated:

Sintx Technologies, Inc.

Sintx Technologies is a material science company founded in 1995, developing silicon nitride ceramics for medical, defense, and industrial uses.

Sintx Technologies, Inc.

Sintx Technologies, Inc. was founded in 1995 in Boulder, Colorado, emerging from material science research at Battelle Memorial Institute. The company focused on developing advanced silicon nitride ceramics, a specialty material with high strength, thermal resistance, and biocompatibility. The strategy centered on licensing and scaling silicon nitride into three verticals: medical implants (artificial joints, spinal fusion devices) under the Amedica brand, armor products for military and commercial vehicles, and industrial components for renewable energy systems. Confirmed customers include Zimmer Biomet for medical ceramics and the US Department of Defense for armor applications. The firm employed roughly 58 staff as of 2022 and maintained a single headquarters in Boulder. In 2022, Sintx sold its Amedica medical implant business to Glantar GmbH, an event that reshaped the company's revenue profile toward the armor and industrial segments. Sintx's structural differentiator is its material platform approach: rather than competing as a standalone medical device or defense contractor, it licenses and co-develops a single proprietary ceramic across sectors. This model reduces capital intensity but requires sustained R&D and regulatory approvals.

Website
sintx.com

General information

Firm type

other

Year founded

1995

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Boulder

Corporate office

Boulder, CO, United States

Principals

Michael J. Sverchek

President and CEO

Sector focus

Industrial TechHealthcare ServicesEnergy Transition & Renewables

Frequently asked questions

Who runs investment decisions at Sintx Technologies?

Michael J. Sverchek serves as President and CEO, leading the company's strategic direction and execution. He has been with Sintx since 2017.

How does Sintx source proprietary deal flow?

Sintx uses its internal R&D team and partnerships with institutions like Battelle Memorial Institute, where its core silicon nitride technology originated.

Is Sintx structured as a family office or a public technology company?

Sintx is a publicly traded company (NASDAQ: SINT) operating as a material science firm, not a family office. Its shares are held by institutional and retail investors.

Which sectors does Sintx explicitly avoid?

Sintx does not invest in software, fintech, or consumer products; its focus remains on advanced ceramics for medical, defense, and industrial applications.

What investment stages does Sintx typically target?

Sintx does not operate as an investment firm. It develops and commercializes its own technology internally.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo